Literature DB >> 4254

Duration of cardiac effects of timolol and propranolol.

M R Achong, K M Piafsky, R I Ogilvie.   

Abstract

The duration of the cardiac effects of single intravenous doses of the beta-antagonists, timolol and propranolol, was compared in 6 healthy male subjects. Timolol and propranolol were given in doses of 1 mg and 10 mg, respectively, and at specified times after their administration, beta-blockade was assessed by the reduction of maximal exercise-induced tachycardia and by the inhibition of the chronotropic and inotropic effects of isoproterenol. Inotropic effects were measured by changes in the pre-ejection period of left ventricular systole obtained from systolic time intervals. There was no statistically significant difference in the timolol and propranolol time-courses of beta-blockade. The change in exercise-tachycardia was maximal 5 min after beta-antagonist infusion but dissipated rapidly so that no statistically significant change was observed 9 hr later. The chronotropic and inotropic effects of isoproterenol were almost completely antagonized for 11/2 hr after beta-antagonist infusion, and significant beta-blockade could be demonstrated 9 hr later. There was no difference in the time-course of the negative chronotropic and inotropic effects of either beta-antagonist.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4254     DOI: 10.1002/cpt1976192148

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.

Authors:  R K Ferguson; P H Vlasses; J R Koplin; G I Holmes; P Huber; J Demetriades; W B Abrams
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

2.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

3.  Plasma timolol levels after oral and intravenous administration.

Authors:  O F Else; H Sorenson; I R Edwards
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

4.  Efficacy of low-dose 90Sr-90Y therapy combined with topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas.

Authors:  Hong-Jian Zhu; Qinghong Liu; Xiao-Li Deng; Yan-Xing Guan
Journal:  Exp Ther Med       Date:  2015-07-01       Impact factor: 2.447

Review 5.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  β-Adrenergic Contributions to Emotion and Physiology During an Acute Psychosocial Stressor.

Authors:  Jennifer K MacCormack; Emma L Armstrong-Carter; Monica M Gaudier-Diaz; Samantha Meltzer-Brody; Erica K Sloan; Kristen A Lindquist; Keely A Muscatell
Journal:  Psychosom Med       Date:  2021 Nov-Dec 01       Impact factor: 4.312

Review 7.  The effectiveness and safety of topical β-receptor blocker in treating superficial infantile haemangiomas: A meta-analysis including 20 studies.

Authors:  Zhenying Lin; Baoxin Zhang; Zhongjing Yu; Huanyuan Li
Journal:  Br J Clin Pharmacol       Date:  2020-01-17       Impact factor: 3.716

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.